PARAGON MEDICAL acquired by NN
Context
The integration of Paragon Medical into the NN, Inc. life sciences portfolio represents a definitive shift in the group's overarching corporate strategy. By absorbing Paragon Medical, NN, Inc. significantly enhances its technical proficiencies and diversifies its finished device offerings, moving beyond traditional industrial components into highly regulated healthcare markets. The strategic rationale for the transaction centers on the fusion of Paragon Medical’s niche leadership in orthopedic instrumentation with NN, Inc.’s global manufacturing scale and materials science depth. This operation allows NN, Inc. to build a more balanced business model, mitigating exposure to volatile industrial cycles by capturing non-discretionary demand in the surgical hardware space. The partnership acts as a catalyst for geographic and technical expansion, providing the strategic resources required to scale Paragon Medical's specialized capabilities across an international platform. Ultimately, the merger consolidates a high-performance life sciences division, positioning the organization as a primary enabler of medical device innovation and precision manufacturing on a global scale.
PARAGON MEDICAL, which reported an EBITDA margin of [members only] in 2017, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Paragon Medical functions as a premier technology-driven organization specializing in the design, engineering, and manufacturing of critical medical components and surgical instruments. The entity’s business model is built on an industrialized framework as a contract development and manufacturing organization (CDMO), providing technical operational depth to global medical device leaders. Its value proposition is anchored in high-precision micro-machining and specialized metallurgy for orthopedic implants, robotic surgical tools, and drug delivery systems. Strategically, the firm focuses on being a mission-critical partner in the healthcare supply chain, offering end-to-end solutions from prototyping to high-volume commercial production. By maintaining a diverse portfolio of single-use instruments and implantable hardware, the organization ensures the structural reliability of advanced therapeutic procedures. The entity prioritizes manufacturing excellence and technical agility to facilitate the rapid scaling of medical innovations in a highly regulated landscape.
Ent. Value
$300–700M
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
15x–25x
EV / EBIT
[members only]
Historical Financials (USD)
Other operations with PARAGON MEDICAL
Other operations with PARAGON MEDICAL
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 11/2023 | AMETEK | PARAGON MEDICAL | UNITED STATES | Medical Devices |
| 04/2020 | AMERICAN SECURITIES | PARAGON MEDICAL | UNITED STATES | Medical Devices |
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2018 | ASTORG | NEMERA | FRANCE | Medical Consumables |
| 08/2018 | DENTRESSANGLE | ACTEON | FRANCE | Medical Devices |
| 05/2018 | Zoetis | Abaxis | UNITED STATES | Diagnostic Equipment |
| 05/2018 | PERMIRA | CORIN GROUP | UNITED KINGDOM | Implants & Prosthetics |
| 12/2017 | PERKINELMER | EUROIMMUN MEDICAL LABORATORY DIAGNOSTICS | GERMANY | Diagnostic Equipment |
| 10/2017 | CVC | SEBIA | FRANCE | Diagnostic Equipment |
| 10/2017 | UI INVESTISSEMENT / BPIFRANCE | THERADIAL | FRANCE | Medical Devices |
| 09/2017 | FRESENIUS | NXSTAGE MEDICAL | UNITED STATES | Diagnostic Equipment |
| 06/2017 | EQT PARTNERS | OTTOBOCK | GERMANY | Implants & Prosthetics |
| 06/2017 | CHARTERHOUSE | SERB | BELGIUM | Pharma & Biotech |
REFERENCES
Valuation range: EV $300–700M
Revenue range: $100–200M
EBITDA range: $10–30M
EV/Revenue range: 2x - 6x
EV/EBITDA range: 15x - 25x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PARAGON MEDICAL by NN are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Target: paragon medical
Acquirer: nn